';
CLOSE
Featured
Featured posts

0 2581

ODP Announcement 21-046 is intended to instruct providers on how to proceed when a claim denial is received for Error Status Codes (ESC) 545 and 512. The short descriptions for these ESCs are “Claim Past Filing Limit” and “Claim Past 365 Day Filing Limit.” Providers should utilize the Bureau of Financial Management and Program Support 180-Day Timely Filing Exception/Special Handling Request Form when requesting payment for these claims. Please note: the release of this communication will obsolete Informational Memo 037-17.

Additionally, Medical Assistance (MA) Regulation 55 Pa. Code § 1101.68(b)(1) established criteria for submitting invoices for services rendered to MA recipients. Please view the regulation here.

0 1261

ODP Announcement 20-056 Update is to release the Office of Developmental Programs’ (ODP) revised Individual Transition Guide. The Guide has been renamed the Supports Coordinator (SC) Guide for Community Reintegration (the Guide).

As communities begin to reopen on a larger scale, people will have different levels of readiness to return to pre-pandemic activities. This guide is designed for SCs supporting individuals, their families, staff, and other involved parties to facilitate conversations to identify supports and services to assist in a successful reentry into the community.

0 1884

On June 11, 2021, the Department of Health and Human Services issued a document titled “Provider Relief Fund General and Targeted Distribution: Post-Payment Notice of Reporting Requirements” to notify Provider Relief Fund (PRF) recipients of the data elements and deadlines that constitute the post payment reporting process. The June 11 PRF requirements establish:

  1. the deadlines by which recipients are required to use or return funds, and
  2. the deadlines by which recipients must submit a report on use of funds.

The previous PRF guidance, titled “General and Targeted Distribution: Post-Payment Notice of Reporting Requirements,” was released on January 15, 2021 and is superseded by the June 11 guidance. Principle differences between the guidance are:

  1. Updated Reporting Times
  2. Updated Payment Use Periods
  3. Reporting Requirement Changes

Please see the document provided to us by ANCOR for the information.

0 1304

Date: Tuesday, June 29, 2021, 1:00 pm ET
Cost: FREE
Duration: 1 hour
Jasleen Chhatwal, MBBS, MD, FAPA
Chief Medical Officer, Sierra Tucson Tucson, Arizona
Offered by the Psychiatry and Behavioral Health Learning Network
Register here

Toxic stress during childhood can harm the most basic levels of the nervous, endocrine, and immune systems, and such exposures can even alter the physical structure of DNA (epigenetic effects). Childhood maltreatment has been linked to various changes in brain structure and function and stress-responsive neurobiological systems with negative downstream impacts on health, emotional well-being, and longevity.

In this presentation, we will explore the mechanisms by which adverse childhood experiences (ACEs) exert their negative impacts. In understanding the effects on the brain, body, and behavior, we will look to solutions that can move us toward improved health outcomes.

Upon completion of this webinar, attendees will be able to:

  • Identify Adverse Childhood Experiences
  • Explain the mechanisms by which ACEs exert longer-term negative impacts
  • List 3 solutions to reduce the morbidity of ACEs Addiction Professionals

This course has been approved by NACCME, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840. NACCME is responsible for all aspects of the programming.

0 1659

As you may know, the Pennsylvania Department of Drug and Alcohol Programs (DDAP) has issued three temporary regulatory suspensions under authority granted by the Governor’s declaration of a disaster emergency due to the coronavirus pandemic. Based on flexibilities granted by the Substance Abuse and Mental Health Services Administration (SAMHSA), DDAP’s goal with these suspensions was to respond to the extraordinary circumstances of the last year by allowing entities regulated by DDAP to continue operating throughout the uncertainty of the pandemic.

On June 10, 2021, the General Assembly passed House Resolution 106, which terminated the Disaster Declaration in whole, effective immediately. However, Governor Wolf signed Act 21 of 2021 on June 11, 2021 to ensure regulatory and statutory suspensions enacted under the Disaster Declaration would continue. Act 21 extends all of the regulatory and statutory suspensions authorized under the Disaster Declaration until September 30, 2021. More information on Act 21 is outlined in this press release from the Governor.

In the table below, you will find the three regulations in which DDAP suspended utilizing the Disaster Declaration. DDAP would like to reiterate that these suspended regulations will continue to be in place until September 30, 2021.

 

Statute/Regulation Statute/Regulation Purpose Waiver benefit/explanation
28 Pa. Code § 715.16(e)

 

 Prohibits narcotic treatment programs (NTPs — methadone clinics) from permitting a patient to receive more than a 2-week take-home supply of medication. In response to COVID-19, SAMHSA is allowing up to 28 days of take-home medications for patients on stable dosages, if the physician deems appropriate.

 
28 Pa. Code § 715.9(a)(4) Requires NTPs to make a face-to-face determination before admission to treatment, for those clients who will receive buprenorphine treatment. In response to COVID-19, SAMHSA is allowing initial evaluations for a patient who will be treated with buprenorphine to be completed via telehealth.
28 Pa. Code § 715.6(d) Requires NTPs to have narcotic treatment physician services onsite. In response to COVID-19, SAMHSA is allowing initial evaluations for a patient who will be treated with buprenorphine to be completed via telehealth.

 

In the coming weeks, DDAP will continue to work with SAMHSA and solicit feedback on the best way to move forward with these suspended regulations to ensure that the drug and alcohol treatment field is able to provide necessary services to patients in the safest, most effective way possible.

Thank you all for your continued work to help better the lives of Pennsylvanians with substance use disorder. If you have any further questions, please do not hesitate to reach out to the Bureau of Program Licensure, Division of Licensing Inspection at (717) 783-8675 or via email.

Prev1...432433434...559Next Page 433 of 559
© 2021 - Rehabilitation & Community Providers Association